The FDA-mandated trial of safety of long-acting beta-agonists in asthma: finality or futility?
Journal Articles
- Overview
- Research
- Identity
- Additional Document Info
- View All
Overview
status
publication date
- February 2013
has subject area
- 1103 Clinical Sciences (FoR)
- Adrenergic beta-Agonists (MeSH)
- Albuterol (MeSH)
- Asthma (MeSH)
- Clinical Trials as Topic (MeSH)
- Delayed-Action Preparations (MeSH)
- Disease Progression (MeSH)
- Drug Therapy, Combination (MeSH)
- Ethanolamines (MeSH)
- Formoterol Fumarate (MeSH)
- Glucocorticoids (MeSH)
- Humans (MeSH)
- Product Surveillance, Postmarketing (MeSH)
- Respiratory System (Science Metrix)
- Salmeterol Xinafoate (MeSH)
- United States (MeSH)
- United States Food and Drug Administration (MeSH)
published in
- Thorax Journal